NEW BIOMEDICAL INTERFACE MATERIALS
NEW BIOMEDICAL INTERFACE MATERIALS
批准号:
2028365
负责人:
ROGER E MARCHANT
金额:
$22.2万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-03-01 至 1998-11-30
关键词:
adsorption antithrombogenic surface atomic force microscopy biomaterial development /preparation biomaterial evaluation fibrinogen fibronectins fluorocarbon polymers human subject hydrocarbons hydropathy infrared spectrometry intermolecular interaction molecular film oligosaccharides platelet activation polyethylenes polymerization polymers radiowave radiation silicone rubber surface property thermodynamics von Willebrand factor
中文摘要
用于心血管假体的生物材料受到众所周知的
与表面引起的血栓形成和感染相关的问题。
这些界面问题是一直存在的主要问题
悬而未决并限制了现有的成功和适用性
生物医学聚合物。
拟议的研究将继续侧重于编制新的
生物医学界面材料,通过新的表面改性
方法,旨在改善宿主对现有
生物材料植入物。具体地说,将使用界面材料
探讨熵排斥力(ERF)的作用
关于血液相容性。将要检验的假设是,ERF
表示吸附的主要决定因素,而
吸附等离子体的组成、组织和功能状态
蛋白质,然后决定随后的细胞和分子表面
互动。我们建议对临床相关的假设进行检验。
生物材料和对照,表面用一系列界面修饰
材料的范围从疏水性到亲水性,随着
通过射频等离子体聚合制备的水合度,
到用于最大化ERF的高度溶剂化低聚糖,
新型寡糖-碳氢-低聚糖(OHO)的制备
三嵌段生物聚合物将通过坚固的结合到测试表面
疏水相互作用。每一次表面改性都将表征
通过光谱和物理方法,包括原子力
显微镜(AFM)将允许在亚分子水平上进行成像
以及分子间作用力的检验。该系统的稳定性
将界面材料暴露在水、缓冲液中后进行测定
和动态流动条件下的十二烷基硫酸钠溶液。的影响
血浆蛋白和血小板表面的界面性质与ERF
相互作用将在体外通过测定在静态条件下进行
和动态流动条件,(L)的量、成分和
吸附的关键血浆蛋白的功能完整性
蛋白质~溶液,黏附蛋白耗尽的介质,以及人类
血浆.使用放射性标记法、红外光谱分析和免疫标记法
利用单抗黏附蛋白质的技术和亚分子原子力显微镜
蛋白质的成像;以及(2)蛋白质的数量和功能状态
吸附的血小板。
从这些研究中,我们将尝试通过以下方式确定其机制
界面性质和电流变液的哪一种变化会影响
黏附蛋白的吸附和功能状态,以及这是如何
与血液相容性有关。拟议的研究,如果
成功,将导致重要的新班级的发展
对蛋白质具有抵抗力的生物医学界面材料
吸附。
英文摘要
Biomaterials used in cardiovascular prostheses suffer from well-known
problems associated with surface-induced thrombosis and infection.
These interfacial problems are major concerns that have remained
unresolved and limited the success and applicability of existing
biomedical polymers.
The proposed studies will continue to focus on the preparation of new
biomedical interface materials, through novel surface modification
methodologies, designed to improve the host response to existing
biomaterial implants. Specifically, interface materials will be used
to investigate of the role of entropic repulsive hydration forces (ERF)
on blood compatibility. The hypothesis that will be tested is that ERF
represents a major determining factor in the adsorption, and the
composition, organization and functional state of adsorbed plasma
proteins, which then determines subsequent cell and molecular surface
interactions. We propose to test the hypothesis on clinically-relevant
biomaterials and controls, surface-modified with a series of interface
materials that range from hydrophobic, to hydrophilic with increasing
degree of hydration, prepared by radiofrequency plasma polymerization,
to highly solvated oligosaccharides that will used to maximize ERF,
prepared from novel oligosaccharide-hydrocarbon-oligosaccharide (OHO)
triblock biopolymers that will be bound to test surfaces by strong
hydrophobic interaction. Each surface modification will characterized
by spectroscopic and physical methods, including atomic force
microscopy (AFM) which will permit imaging at the submolecular level
and examination of the intermolecular forces. The stability of the
interface materials will be determined after exposure to water, buffer
and SDS solution, under dynamic flow conditions. The effect of
interfacial properties and ERF on plasma protein and platelet-surface
interactions will be investigated in vitro by determining, under static
and dynamic flow conditions, (l) the amount, composition, and
functional integrity of key plasma proteins adsorbed from
protein~solutions, media depleted of adhesive proteins, and human
plasma; using radiolabel methods, infrared spectroscopy, immunolabel
techniques employing Mab to adhesive proteins, and by submolecular AFM
imaging of proteins; and (2) the amount and functional state of
adsorbed platelets.
From these studies, we shall attempt to determine the mechanism by
which alteration in interfacial properties and ERF affects the
adsorption and functional state of adhesive proteins, and how this
correlates to blood compatibility. The proposed research, if
successful, will lead to the development of important new classes of
biomedical interface materials, that exhibit resistance to protein
adsorption.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vascularization of polymeric tissue beds
-
批准号:7828505
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:ROGER E MARCHANT
-
依托单位:
Vascularization of polymeric tissue beds
-
批准号:7935299
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:ROGER E MARCHANT
-
依托单位:
Biomimetic Engineering of Vascular Prostheses
-
批准号:7575728
-
项目类别:
-
资助金额:$44.91万
-
财政年份:2008
-
负责人:ROGER E MARCHANT
-
依托单位:
Biomimetic Engineering of Vascular Prostheses
-
批准号:7372150
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2008
-
负责人:ROGER E MARCHANT
-
依托单位:
Biomimetic Engineering of Vascular Prostheses
-
批准号:7799769
-
项目类别:
-
资助金额:$52.48万
-
财政年份:2008
-
负责人:ROGER E MARCHANT
-
依托单位:
Cell-Selective Liposomal Drug Delivery In Restenosis
-
批准号:6729145
-
项目类别:
-
资助金额:$34.16万
-
财政年份:2002
-
负责人:ROGER E MARCHANT
-
依托单位:
Cell-Selective Liposomal Drug Delivery In Restenosis
-
批准号:6623483
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2002
-
负责人:ROGER E MARCHANT
-
依托单位:
Cell-Selective Liposomal Drug Delivery In Restenosis
-
批准号:6466235
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2002
-
负责人:ROGER E MARCHANT
-
依托单位:
Cell-Selective Liposomal Drug Delivery In Restenosis
-
批准号:6872197
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2002
-
负责人:ROGER E MARCHANT
-
依托单位:
SURFACE AND LIGAND RECEPTOR INTERACTIONS OF VWF
-
批准号:2750625
-
项目类别:
-
资助金额:$19.89万
-
财政年份:1997
-
负责人:ROGER E MARCHANT
-
依托单位:
SURFACE AND LIGAND RECEPTOR INTERACTIONS OF VWF
-
批准号:2372966
-
项目类别:
-
资助金额:$19.06万
-
财政年份:1997
-
负责人:ROGER E MARCHANT
-
依托单位:
SURFACE AND LIGAND RECEPTOR INTERACTIONS OF VWF
-
批准号:6043981
-
项目类别:
-
资助金额:$25.72万
-
财政年份:1997
-
负责人:ROGER E MARCHANT
-
依托单位:
New Biomedical Interface Materials
-
批准号:6948212
-
项目类别:
-
资助金额:$34.43万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:2219478
-
项目类别:
-
资助金额:$21.49万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
New Biomedical Interface Materials
-
批准号:7115826
-
项目类别:
-
资助金额:$33.62万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:6536919
-
项目类别:
-
资助金额:$28.54万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:6638275
-
项目类别:
-
资助金额:$24.82万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:2219477
-
项目类别:
-
资助金额:$21.3万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
New Biomedical Interface Materials
-
批准号:7267689
-
项目类别:
-
资助金额:$32.64万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位:
NEW BIOMEDICAL INTERFACE MATERIALS
-
批准号:3471873
-
项目类别:
-
资助金额:$11.48万
-
财政年份:1988
-
负责人:ROGER E MARCHANT
-
依托单位: